References
Alderman E.L.; Davies, R.O.; Friedman, J.P.; Graham, A.F.; Matlof, H.J. and Harrison, D.C.: Practolol in patients with angina pectoris. Clinical Pharmacology and Therapeutics (In press).
Alderman, E.L.; Coltart, D.J.; Wettick, R.A. and Harrison, D.C.: Rebound coronary artery syndrome resulting from sudden propranolol withdrawal (Submitted).
Ahlquist, R.P.: Study of adrenotropic receptors. American Journal of Physiology 153: 586 (1948).
Beumer, H.M.: Adverse effects of β-adrenergic receptor blocking drugs on respiratory function. Drugs 7: 130(1974).
Coltart, D.J.; Alderman, E.L.; Robison, S.L. and Harrison, D.C.: The effects of propranolol on left ventricular function, segmental wall motion and diastolic compliance in man. (In preparation).
Flamm, M.D.; Harrison, D.C. and Hancock, E.W.: Muscular subaortic stenosis: prevention of outflow obstruction with propranolol. Circulation 38: 846 (1968).
Furberg, CD.: β-Adrenergic receptor blocking drugs in hypertrophic obstructive cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot’s tetralogy. Drugs 7: 106 (1974).
Gianelly, R.E.; Goldman, R.H.; Treister, B. and Harrison, D.C.: Propranolol in patients with angina pectoris. Annals of Internal Medicine 67: 1216 (1967).
Gibson, D.G.: Pharmacodynamic properties of β-adrenergic receptor blocking drugs in man. Drugs 7: 8(1974).
Greenblatt, D.J. and Koch-Weser, J.: Adverse reactions to β-adrenergic receptor blocking drugs: A report from the Boston Collaborative Drug Surveillance Program. Drugs 7: 118 (1974).
Harrison, DC: Circulatory Effects and Clinical Uses of β-adrenergic Blocking Drugs (Excerpta Medica, Amsterdam 1971).
Harrison, D.C. and Alderman, E.L.: β-adrenergic blockade - 1972. Pharmacology and clinical use. American Journal of Cardiology 29: 165 (1972).
Isaeff, D.M.; Gaston, J.H. and Harrison, D.C.: Long-term monitoring in the Wolff-Parkinson-White syndrome for arrhythmias. Journal of the American Medical Association 222: 449 (1972).
Kattus, A.A; Ross, G. and Hall, V.: Cardiovascular β-Adrenergic Responses (Univ. Calif. Press Los Angeles 1970).
Laragh, J.H.; Baer, L.; Brunner, H.R.; Buhler, F.R.; Sealey, J.E. and Vaughn, E.D., Jr.: Renin, angiotensin and aldosterone system in the pathogenesis and management of hypertensive vascular disease. American Journal of Medicine 52: 633 (1972).
Lefkowitz, R.J. and Haber, E.: A fraction of ventricular myocardium that has the specificity of the cardiac β-receptors. Proceedings of the National Academy of Science USA 68: 1773 (1971).
Popp, R.L. and Harrison, D.C.: Ultrasound in the diagnosis and evaluation and therapy of idiopathic hypertrophic subaortic stenosis. Circulation. 40: 905 (1969).
Prichard, B.N.C: β-Adrenergic receptor blocking drugs in angina pectoris. Drugs 7: 55 (1974).
Shand, D.G.: Pharmacokinetic properties of β-adrenergic receptor blocking drugs. Drugs 7: 39 (1974).
Simpson, F.O.: β-Adrenergic receptor blocking drugs in hypertension. Drugs 7: 85 (1974).
Stephens, S.A.: Unwanted effects of propranolol. American Journal of Cardiology 18: 463 (1966).
Turner, P.: β-Adrenergic receptor blocking drugs in hyperthyroidism. Drugs 7: 48 (1974).
Author information
Authors and Affiliations
Additional information
This work was supported in part by NIH Grants HL-5709, HL-5866, and Grant NIH RR-70 from Division of Research Resources, General Clinical Research Center Branch
Rights and permissions
About this article
Cite this article
Harrison, D.C. The Pharmacology and Therapeutic Use of β-Adrenergic Receptor Blocking Drugs in Cardiovascular Disease. Drugs 7, 1–7 (1974). https://doi.org/10.2165/00003495-197407010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197407010-00001